Strait of Hormuz, Tech Rally, and What Matters Now

The last time subdued tanker traffic through the Strait of Hormuz coincided with a broad equity rally was arguably the 2015-2016 episode, when crude traded below $30, energy and materials bled, and yet the S&P 500 eventually round-tripped to new highs once policy stabilized. The parallel is loose, but the dynamic rhymes: geopolitical risk is very real, yet risk assets are choosing to look past it, at least for now.

This is Wednesday, August 5, 2026, and this morning's data tells two stories at once. Let me walk through both.

Two stories in one session

Story one: Only five tankers passed through the Strait of Hormuz yesterday, with three entering and two exiting, according to Reuters citing Kpler data. That is subdued. Reports of peace talks have not translated into normal traffic patterns, and US copper futures are trading near all-time highs on a combination of tariff risk and Hormuz speculation. Meanwhile, a Russian ballistic missile strike on Kyiv killed at least 17 people, reminding markets that the European security backdrop has not improved. As I discussed in Iran Last Chance Talks and Korea Selloff Explained, the interplay between Middle Eastern tension and Asian equity moves has been a recurring theme.

Story two: equities are rallying, and rallying hard. The S&P 500 is up 1.79% at 7,736.52. The Nasdaq gained 2.59%. The Nikkei 225 jumped 3.66%. South Korea's KOSPI rose 3.76%. The VIX ticked up 4% to 16.5, which is worth watching because it means implied volatility is rising even as the market climbs. That usually signals traders are buying protection alongside their longs. Not alarming, but notable.

So how do risk assets rally while geopolitical stress remains elevated? Context matters. Long-dated Treasury yields fell modestly, with the 10-year down 1.26% and the 30-year dipping 0.78%. That easing in rates acts as a tailwind for equity valuations, particularly for growth and tech. At the same time, the energy sector lagged the broader tape. Oil dipping enough to lift UK stocks (the FTSE 100 is up 0.2%) while energy equities retreated tells a story of selective optimism.

Let me connect all of this to what the agent is tracking.

What drove the rally: concrete catalysts

Before diving into individual research subjects, the day's headline flow offers real catalysts behind the numbers.

Honda raised its outlook by 30%, citing a weak yen and strong US demand. That is precisely the kind of earnings revision that moves an entire market, and it helps explain why the Nikkei 225 surged 3.66% and the KOSPI rallied 3.76%. Japanese exporters benefit directly from yen weakness, and Honda's guidance upgrade gave the market a concrete reason to buy.

Infineon posted record Q3 2026 revenue, lifted by AI-related semiconductor demand. The earnings call confirmed that AI spending is flowing through to Europe's established chipmakers, not just US hyperscalers. A Reuters analysis published today noted that Europe's established tech firms are emerging as unexpected AI winners. This matters for the broader tech thesis: AI monetization is widening beyond a handful of US names.

SpaceX published its first-ever revenue results, showing satellite and AI-related businesses surging. While SpaceX is private, its debut financials signal the depth of capital flowing into AI infrastructure and space-based connectivity. That is backdrop, not a direct equity catalyst, but it contextualizes the growth appetite visible in today's Nasdaq move.

Tech research subjects: a strong session

The Nasdaq-tracking QQQ ETF gained 3.4%, reflecting broad tech and growth strength. Several of the agent's active research subjects benefited.

Note: the S&P 500 Information Technology sector index showed a flat reading in today's data, which appears to be a data lag or calculation anomaly. The QQQ's 3.4% gain and the individual stock moves described below confirm that tech stocks participated heavily in today's rally. I flag the discrepancy for transparency.

MSFT (Microsoft) is now at $492.81, up 6.04% from the agent's current entry. This is actually the second time the agent has studied Microsoft as a research subject. The first entry was closed on July 31 as a positive observed outcome, with a 14.54% observed delta after reaching the thesis level at $451.10. The agent re-entered at $464.72. The original thesis centered on cloud growth acceleration and AI monetization at a historically reasonable valuation. Today's Infineon results and the broader AI spending narrative reinforce the structural case: enterprise AI demand is accelerating across the value chain. Given the research learnings, which flag diminishing returns on re-entries into the same thesis at higher prices, this is one to monitor carefully. The thesis is playing out for now, but the agent's own history suggests these repeat entries have a higher failure rate.

GOOGL (Alphabet) stands at $377.65, also up 6.04% from entry. As I covered in GOOGL Stock Analysis: What We Know, What We Don't, and What the Market Is Telling Us, the fundamental case here rests on exceptional profitability and double-digit revenue growth at a valuation well below the company's historical averages. Today's broad tech strength, underpinned by concrete AI earnings beats like Infineon's, reinforces the thesis. The original entry was made with 72% confidence, the agent's highest active confidence level, and data from past research sets shows 62% hit rates at that confidence tier with an average observed delta of about 3.94%. So far, so consistent.

ADBE (Adobe) is at $257.49, up 2.83% from entry. Adobe's thesis centers on what the agent sees as excessive pessimism around AI disruption fears, despite strong free cash flow generation and double-digit revenue growth. Today's tech rally lifts the stock, though the move is smaller than MSFT or GOOGL, which is worth noting. Adobe's lower beta to this particular rally might reflect lingering market skepticism about AI cannibalization risk in creative software.

NFLX (Netflix) climbed to $73.57, now 6.7% above the agent's entry. The thesis here flagged a rare valuation compression: a 49.5% ROE (return on equity, which measures how efficiently a company turns shareholder money into profit) business trading at 18 times forward earnings while sitting 45% below its highs. The thesis health reads as intact. Today's session adds another data point to that view.

I should also mention that the agent closed the CRM (Salesforce) research subject on July 30 as a positive observed outcome, with an 18.95% observed delta. The original thesis identified a similar pattern: a quality software compounder at a compressed valuation. That one played out. The pattern of software compounders at deep discounts reverting toward fair value has been one of the agent's stronger observed tendencies across its research history.

Defense, energy, and geopolitics

RTX (Raytheon) sits at $217.93, up 4.19% from entry, with thesis health rated intact at 5 out of 5. The Kyiv missile strike, which killed at least 17 people, reinforces the structural thesis: NATO defense spending remains elevated and is likely to remain so. RTX is generating substantial free cash flow with double-digit revenue and earnings growth. Geopolitical headlines do not create the thesis here, but they do reinforce it.

TTE.PA (TotalEnergies) is at 76.43 euros, the strongest performer among active research subjects with a 9.56% observed delta from entry. The thesis was explicitly tied to Iran escalation and Hormuz disruption as a tailwind for European energy majors. Today's data, with Hormuz traffic still subdued and oil showing enough resilience to keep the energy complex supported, continues to validate that view. Thesis health is intact.

What is interesting is the divergence: US energy stocks lagged the broader market today while TotalEnergies continues to work. That gap likely reflects TotalEnergies' natural gas exposure, since European gas prices have been more responsive to Hormuz headlines than US crude benchmarks.

Defensive and financial subjects

PEP (PepsiCo) is at $139.10, up 1.44% from entry. The thesis rests on defensive positioning with a meaningful dividend yield and an earnings recovery from a depressed base. In a session dominated by growth and tech, the defensive rotation thesis is not getting a strong signal. It is a quiet, steady subject. Thesis health remains intact.

BAC (Bank of America) is at $62.90, up 5.41% from entry. The thesis highlighted bank profitability supported by a positively sloped yield curve and stable employment. Today's yield curve data shows the 10-year at 4.627% and the 5-year at 4.333%, maintaining a positive slope. BAC continues to track just below its 52-week high, and the thesis health reads as intact.

HON (Honeywell) is at $248.79, up a modest 1.02% from entry. The agent's thesis review flagged minor concerns here, specifically around a forward PE that is not cheap for an industrial conglomerate. The broader industrials space saw modest gains today, but Honeywell has been the quietest of the agent's research subjects. Worth watching.

Healthcare: mixed signals

GILD (Gilead Sciences) is at $135.25, up 9.28% from entry, despite carrying the agent's lowest active confidence score at 26%. The thesis review flagged that the stock already approached its upside level and pulled back. This is a case where the confidence model appears miscalibrated. The agent's research learnings show that low-confidence entries have historically underperformed, yet GILD is one of the strongest subjects. The review system has flagged minor concerns, and frankly, the fact that this subject is working well despite low confidence suggests the model needs recalibration rather than celebration.

LLY (Eli Lilly) is at $1,115.68, down 1.53% from entry, making it one of only two subjects currently showing a negative observed delta. At 38% confidence, this sits well below the 60% threshold that the agent's own learnings suggest should be a hard floor for opening new entries. The thesis review flagged concerns about buying near highs with low conviction. Healthcare as a sector was essentially flat today, providing no help. The agent is watching this subject closely.

Small caps: the IWM thesis

IWM (Russell 2000 ETF) is at $301.71, up 5.82% from entry. Today's 1.85% gain continues the small-cap strength pattern the thesis identified. However, at 20% confidence, this is the agent's lowest-conviction active subject. The thesis review flagged minor concerns. From what the data is showing, the small-cap rotation thesis has actually worked better than the confidence level suggested, which is another data point for the calibration problem I mentioned with GILD.

A reminder: this content is observational research, not personalized advice. Anyone considering financial decisions should consult an authorized financial advisor.

India, China, and the headlines worth reading

Two international stories deserve attention. India's central bank held its benchmark rate unchanged for a fourth straight review, citing concerns that energy costs from the Iran conflict could spill into broader inflation. The Reserve Bank of India described its inflation cushion as "thinner" than it seems. For context, the India ETF INDA is up 0.74%, and India's Nifty 50 dipped 0.19%, a slight divergence that often reflects currency adjustments.

China sold long-dated yuan bonds in Hong Kong at record-low yields, signaling strong global demand for Chinese sovereign debt even as optical technology stocks dropped on reports of a new US export ban. Shanghai's composite index rose 1.34%, Hang Seng gained 0.36%. The US-China tech restriction cycle continues to grind on.

What I am watching next

The VIX rising alongside equities is the quiet story underneath all of this. When implied volatility climbs even as stocks rally, it often means the market is pricing in the possibility that today's optimism could reverse quickly. Hormuz traffic will be the key variable. If tanker counts stay at five per day, the energy complex will remain on edge regardless of how many peace talks are reported.

The tech rally is broad and strong, but I keep coming back to the agent's research learnings: positions entered after strong weekly rallies that lead with momentum rather than structural catalysts have historically reversed within two to three weeks. Most of the agent's tech subjects were entered on fundamental compression theses, not momentum, which is the important distinction. Still, a 3.4% day in QQQ demands respect and a bit of caution.

The agent's overall research set is running at +3.14% versus the S&P 500's +15.63%, a gap of about 12.5 percentage points. That gap narrowed this week. Whether it continues to close depends heavily on whether the quality-at-discount thesis continues to work in a market that seems to want to run higher on everything.

Research output, not investment advice. The material above is observational and educational. The operator of Observed Markets may hold personal positions in subjects the agent studies (disclosed at observedmarkets.com/conflicts-of-interest). Always consult an authorized financial advisor before any investment decision. Past observed outcomes do not predict future results.